Definitive Contract 75N95024C00037

Award Date 9/25/24
Potential Completion Date 5/1/25
Potential Value $750K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a $41,290,502.86 firm-fixed-price definitive contract to Verily Life Sciences LLC, doing business as G L S, for wastewater surveillance testing. The contract has an ultimate completion date of August 6, 2026 and was awarded on January 12, 2024 without any set-aside designation. Verily Life Sciences, a subsidiary of Alphabet Inc., specializes in collecting, organizing, and activating health data, and has provided wastewater surveillance...
This is a firm fixed price purchase order (contract) awarded by the Defense Health Agency to Biobot Analytics Inc., a self-certified small disadvantaged business, to provide SARS-COV-2 analytical services. The contract is valued at $129,600.00 and has a completion date of March 13, 2025. The original solicitation was set aside for total small business and required the contractor to provide ribonucleic acid (RNA) virus detection using quantitative polymerase chain reaction (qPCR) and reverse...
This $1,786,400.00 firm fixed price purchase order contract was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Amprion, Inc., a for-profit company specializing in neurological diagnostic services. The contract is for protein analysis services focused on detecting alpha-synuclein aggregates in cerebrospinal fluid samples, utilizing Amprion's proprietary SYNTap assay technology. The contract has a period of...
This contract was awarded by the Department of Health and Human Services National Institutes of Health to Alpha Genesis Inc., a for-profit S-corporation that provides nonhuman primates and bio research services. The $135,000.00 firm fixed-price delivery order is for per diem and testing costs associated with a nonhuman primate colony transferred from the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to the National Institute of Allergy and Infectious Diseases...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $8,046,548.00 cost-plus-fixed-fee delivery order contract to Alpha Genesis Inc., a for-profit Subchapter S Corporation, to provide specific pathogen free nonhuman primate breeding colonies in support of NIAID research programs. This contract is part of a larger indefinite delivery/indefinite quantity contract vehicle held by Alpha Genesis to enable...
This firm fixed price purchase order from the Department of Health and Human Services (HHS) awards Biobot Analytics Inc. $1.94 million to provide COVID-19 wastewater data testing services. The contract supports HHS' Office of the Assistant Secretary for Administration under the Coronavirus COVID-19 national interest code. Per the solicitation, Biobot will collect and test samples from at least 320 wastewater treatment facilities serving over 100 million U.S. citizens across all 50 states and...
This is a delivery order contract awarded to Alpha Genesis Inc., a for-profit Subchapter S Corporation that provides nonhuman primate products and biomedical research services. The contract, valued at $500,000.00, is to provide per diem and testing services to support the National Institutes of Health (NIH) National Institute of Mental Health (NIMH) nonhuman primate colony, in accordance with the contract statement of work. The contract has a period of performance through September 17, 2025...
This is a delivery order under Contract # 75N98021D00017 awarded to Alpha Genesis Inc., a for-profit Subchapter S Corporation, by the Office of Logistics and Acquisition Operations (OLAO) on behalf of the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $52,000 firm-fixed-price contract is for per diem, testing, and transportation services related to the provision of nonhuman primates to support NIAID's research...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Envigo Global Services Inc. (a subsidiary of Laboratory Corporation of America Holdings) for $5,305.60. The contract is for the provision of research models, specifically non-human primates such as cynomolgus, rhesus, and Chinese-origin macaques, along with associated services including...
This is a $26,934,378.00 definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Alpha Genesis Inc., a for-profit Subchapter S corporation, to breed and maintain a free-ranging colony of approximately 3,000 rhesus monkeys on Morgan Island, South Carolina. The contract has an ultimate completion date of September 6, 2028. This contract was awarded under a previous...

This is a definitive contract awarded by the National Institute on Aging, a civilian agency, to Verily Life Sciences LLC, a for-profit limited liability company. The contract, worth $750,000.00, is for firm-fixed-price wastewater surveillance testing services to support disease monitoring programs, particularly for COVID-19 and monkeypox. The contract does not have a set-aside designation, indicating it was competed openly. The period of performance extends through May 1, 2025, demonstrating the agency's long-term commitment to Verily's wastewater surveillance capabilities. Verily is a subsidiary of Alphabet Inc. and specializes in collecting, organizing, and activating health data to develop innovative technological solutions for federal healthcare and public health agencies.

Generated 5/2/25, 10:19 AM